Literature DB >> 8037205

Nature and recurrence of AVPR2 mutations in X-linked nephrogenic diabetes insipidus.

D G Bichet1, M Birnbaumer, M Lonergan, M F Arthus, W Rosenthal, P Goodyer, H Nivet, S Benoit, P Giampietro, S Simonetti.   

Abstract

X-linked nephrogenic diabetes insipidus (NDI) is a rare disease with defective renal and extrarenal arginine-vaso-pressin V2 receptor responses due to mutations in the AVPR2 gene in Xq28. We analyzed 31 independent NDI families to determine the nature and recurrence of AVPR2 mutations. Twenty-one new putative disease-causing mutations were identified: 113delCT, 253del35, 255de19, 274insG, V88M, R106C, 402delCT, C112R, Y124X, S126F, W164S, S167L, 684delTA, 804insG, W284X, A285P, W293X, R337X, and three large deletions or gene rearrangements. Five other mutations--R113W, Y128S, R137H, R181C, and R202C--that previously had been reported in other families were detected. There was evidence for recurrent mutation for four mutations (R113W, R137H, S167L, and R337X). Eight de novo mutation events were detected (274insG, R106C, Y128S, 167L [twice], R202C, 684delTA, and R337X). The origins were maternal (one), grandmaternal (one), and grandpaternal (six). In the 31 NDI families and 6 families previously reported by us, there is evidence both for mutation hot spots for nucleotide substitutions and for small deletions and insertions. More than half (58%) of the nucleotide substitutions in 26 families could be a consequence of 5-methyl-cytosine deamination at a CpG dinucleotide. Most of the small deletions and insertions could be attributed to slipped mispairing during DNA replication.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8037205      PMCID: PMC1918376     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  21 in total

Review 1.  DNA structure, mutations, and human genetic disease.

Authors:  R R Sinden; R D Wells
Journal:  Curr Opin Biotechnol       Date:  1992-12       Impact factor: 9.740

2.  Fragile X founder effect?

Authors:  A Chakravarti
Journal:  Nat Genet       Date:  1992-07       Impact factor: 38.330

3.  Brief report: a molecular defect in the vasopressin V2-receptor gene causing nephrogenic diabetes insipidus.

Authors:  E J Holtzman; H W Harris; L F Kolakowski; L M Guay-Woodford; B Botelho; D A Ausiello
Journal:  N Engl J Med       Date:  1993-05-27       Impact factor: 91.245

4.  Brief report: a mutation in the vasopressin V2-receptor gene in a kindred with X-linked nephrogenic diabetes insipidus.

Authors:  J J Merendino; A M Speigel; J D Crawford; A M O'Carroll; M J Brownstein; S J Lolait
Journal:  N Engl J Med       Date:  1993-05-27       Impact factor: 91.245

5.  X-linked nephrogenic diabetes insipidus mutations in North America and the Hopewell hypothesis.

Authors:  D G Bichet; M F Arthus; M Lonergan; G N Hendy; A J Paradis; T M Fujiwara; K Morgan; M C Gregory; W Rosenthal; A Didwania
Journal:  J Clin Invest       Date:  1993-09       Impact factor: 14.808

6.  A Null mutation in the vasopressin V2 receptor gene (AVPR2) associated with nephrogenic diabetes insipidus in the Hopewell kindred.

Authors:  E J Holtzman; L F Kolakowski; D O'Brien; J D Crawford; D A Ausiello
Journal:  Hum Mol Genet       Date:  1993-08       Impact factor: 6.150

7.  X-linked nephrogenic diabetes insipidus: from the ship Hopewell to RFLP studies.

Authors:  D G Bichet; G N Hendy; M Lonergan; M F Arthus; S Ligier; Z Pausova; R Kluge; H Zingg; P Saenger; E Oppenheimer
Journal:  Am J Hum Genet       Date:  1992-11       Impact factor: 11.025

8.  Mutations in the V2 vasopressin receptor gene are associated with X-linked nephrogenic diabetes insipidus.

Authors:  Y Pan; A Metzenberg; S Das; B Jing; J Gitschier
Journal:  Nat Genet       Date:  1992-10       Impact factor: 38.330

9.  Mutations in the vasopressin type 2 receptor gene (AVPR2) associated with nephrogenic diabetes insipidus.

Authors:  A M van den Ouweland; J C Dreesen; M Verdijk; N V Knoers; L A Monnens; M Rocchi; B A van Oost
Journal:  Nat Genet       Date:  1992-10       Impact factor: 38.330

10.  Nephrogenic diabetes insipidus. A V2 vasopressin receptor unable to stimulate adenylyl cyclase.

Authors:  W Rosenthal; A Antaramian; S Gilbert; M Birnbaumer
Journal:  J Biol Chem       Date:  1993-06-25       Impact factor: 5.157

View more
  36 in total

1.  V2 vasopressin receptor (V2R) mutations in partial nephrogenic diabetes insipidus highlight protean agonism of V2R antagonists.

Authors:  Kazuhiro Takahashi; Noriko Makita; Katsunori Manaka; Masataka Hisano; Yuko Akioka; Kenichiro Miura; Noriyuki Takubo; Atsuko Iida; Norishi Ueda; Makiko Hashimoto; Toshiro Fujita; Takashi Igarashi; Takashi Sekine; Taroh Iiri
Journal:  J Biol Chem       Date:  2011-12-05       Impact factor: 5.157

2.  Mutations in the AVPR2, AVP-NPII, and AQP2 genes in Turkish patients with diabetes insipidus.

Authors:  Duygu Duzenli; Emel Saglar; Ferhat Deniz; Omer Azal; Beril Erdem; Hatice Mergen
Journal:  Endocrine       Date:  2012-05-29       Impact factor: 3.633

3.  Novel mutations associated with nephrogenic diabetes insipidus. A clinical-genetic study.

Authors:  Alejandro García Castaño; Gustavo Pérez de Nanclares; Leire Madariaga; Mireia Aguirre; Sara Chocron; Alvaro Madrid; Francisco Javier Lafita Tejedor; Mercedes Gil Campos; Jaime Sánchez Del Pozo; Rafael Ruiz Cano; Mar Espino; Jose Maria Gomez Vida; Fernando Santos; Victor Manuel García Nieto; Reyner Loza; Luis Miguel Rodríguez; Emilia Hidalgo Barquero; Nikoleta Printza; Juan Antonio Camacho; Luis Castaño; Gema Ariceta
Journal:  Eur J Pediatr       Date:  2015-04-23       Impact factor: 3.183

Review 4.  Diabetes insipidus.

Authors:  P H Baylis; T Cheetham
Journal:  Arch Dis Child       Date:  1998-07       Impact factor: 3.791

5.  Molecular recognition of peptide and non-peptide ligands by the extracellular domains of neurohypophysial hormone receptors.

Authors:  J Howl; M Wheatley
Journal:  Biochem J       Date:  1996-07-15       Impact factor: 3.857

Review 6.  Congenital nephrogenic diabetes insipidus: the current state of affairs.

Authors:  Daniel Wesche; Peter M T Deen; Nine V A M Knoers
Journal:  Pediatr Nephrol       Date:  2012-03-17       Impact factor: 3.714

7.  Identification, characterization and rescue of a novel vasopressin-2 receptor mutation causing nephrogenic diabetes insipidus.

Authors:  Sayali A Ranadive; Baran Ersoy; Helene Favre; Clement C Cheung; Stephen M Rosenthal; Walter L Miller; Christian Vaisse
Journal:  Clin Endocrinol (Oxf)       Date:  2008-12-18       Impact factor: 3.478

8.  Wilms tumor arising in a child with X-linked nephrogenic diabetes insipidus.

Authors:  Reyhan El-Kares; Pierre-Alain Hueber; Miriam Blumenkrantz; Diana Iglesias; Kim Ma; Nada Jabado; Daniel G Bichet; Paul Goodyer
Journal:  Pediatr Nephrol       Date:  2009-03-18       Impact factor: 3.714

9.  Identification of two new mutations in the GPR98 and the PDE6B genes segregating in a Tunisian family.

Authors:  Mounira Hmani-Aifa; Zeineb Benzina; Fareeha Zulfiqar; Houria Dhouib; Amber Shahzadi; Abdelmonem Ghorbel; Ahmed Rebaï; Peter Söderkvist; Sheikh Riazuddin; William J Kimberling; Hammadi Ayadi
Journal:  Eur J Hum Genet       Date:  2008-10-15       Impact factor: 4.246

10.  Clinical characteristics of eight patients with congenital nephrogenic diabetes insipidus.

Authors:  Haruo Mizuno; Yukari Sugiyama; Yoichiro Ohro; Hiroki Imamine; Masanori Kobayashi; Sei Sasaki; Sinichi Uchida; Hajime Togari
Journal:  Endocrine       Date:  2004-06       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.